Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

COO vs HOLX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
COO
The Cooper Companies, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$11.97B
5Y Perf.-22.9%
HOLX
Hologic, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$16.97B
5Y Perf.+42.6%

COO vs HOLX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
COO logoCOO
HOLX logoHOLX
IndustryMedical - Instruments & SuppliesMedical - Instruments & Supplies
Market Cap$11.97B$16.97B
Revenue (TTM)$4.15B$4.13B
Net Income (TTM)$401M$544M
Gross Margin64.2%52.8%
Operating Margin17.2%17.5%
Forward P/E13.2x17.2x
Total Debt$2.78B$2.63B
Cash & Equiv.$111M$1.96B

COO vs HOLXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

COO
HOLX
StockMay 20May 26Return
The Cooper Companie… (COO)10077.1-22.9%
Hologic, Inc. (HOLX)100142.6+42.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: COO vs HOLX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HOLX leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. The Cooper Companies, Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
COO
The Cooper Companies, Inc.
The Growth Play

COO is the clearest fit if your priority is growth exposure.

  • Rev growth 5.1%, EPS growth -4.6%, 3Y rev CAGR 7.3%
  • 5.1% revenue growth vs HOLX's 1.7%
  • Lower P/E (13.2x vs 17.2x)
Best for: growth exposure
HOLX
Hologic, Inc.
The Income Pick

HOLX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • beta 0.41
  • 124.3% 10Y total return vs COO's 57.9%
  • Lower volatility, beta 0.41, Low D/E 52.0%, current ratio 3.75x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCOO logoCOO5.1% revenue growth vs HOLX's 1.7%
ValueCOO logoCOOLower P/E (13.2x vs 17.2x)
Quality / MarginsHOLX logoHOLX13.2% margin vs COO's 9.7%
Stability / SafetyHOLX logoHOLXBeta 0.41 vs COO's 0.93
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)HOLX logoHOLX+37.1% vs COO's -24.8%
Efficiency (ROA)HOLX logoHOLX6.1% ROA vs COO's 3.2%, ROIC 9.4% vs 4.8%

COO vs HOLX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

COOThe Cooper Companies, Inc.
FY 2025
Coopervision Segment
67.0%$2.7B
Coopersurgical Segment
33.0%$1.3B
HOLXHologic, Inc.
FY 2025
Diagnostics
44.6%$1.8B
Breast Health
36.2%$1.5B
Gyn Surgical
16.6%$680M
Skeletal Health
2.7%$109M

COO vs HOLX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHOLXLAGGINGCOO

Income & Cash Flow (Last 12 Months)

Evenly matched — COO and HOLX each lead in 3 of 6 comparable metrics.

COO and HOLX operate at a comparable scale, with $4.2B and $4.1B in trailing revenue. Profitability is closely matched — net margins range from 13.2% (HOLX) to 9.7% (COO). On growth, COO holds the edge at +6.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
RevenueTrailing 12 months$4.2B$4.1B
EBITDAEarnings before interest/tax$1.0B$974M
Net IncomeAfter-tax profit$401M$544M
Free Cash FlowCash after capex$333M$1000M
Gross MarginGross profit ÷ Revenue+64.2%+52.8%
Operating MarginEBIT ÷ Revenue+17.2%+17.5%
Net MarginNet income ÷ Revenue+9.7%+13.2%
FCF MarginFCF ÷ Revenue+8.0%+24.2%
Rev. Growth (YoY)Latest quarter vs prior year+6.2%+2.5%
EPS Growth (YoY)Latest quarter vs prior year+26.9%-9.2%
Evenly matched — COO and HOLX each lead in 3 of 6 comparable metrics.

Valuation Metrics

COO leads this category, winning 4 of 6 comparable metrics.

At 30.5x trailing earnings, HOLX trades at a 7% valuation discount to COO's 32.7x P/E. On an enterprise value basis, COO's 13.2x EV/EBITDA is more attractive than HOLX's 17.4x.

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
Market CapShares × price$12.0B$17.0B
Enterprise ValueMkt cap + debt − cash$14.6B$17.6B
Trailing P/EPrice ÷ TTM EPS32.68x30.53x
Forward P/EPrice ÷ next-FY EPS est.13.24x17.21x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.24x17.39x
Price / SalesMarket cap ÷ Revenue2.93x4.14x
Price / BookPrice ÷ Book value/share1.48x3.43x
Price / FCFMarket cap ÷ FCF27.60x18.44x
COO leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

HOLX leads this category, winning 8 of 9 comparable metrics.

HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $5 for COO. COO carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to HOLX's 0.52x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs COO's 5/9, reflecting strong financial health.

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
ROE (TTM)Return on equity+4.8%+11.0%
ROA (TTM)Return on assets+3.2%+6.1%
ROICReturn on invested capital+4.8%+9.4%
ROCEReturn on capital employed+6.1%+8.8%
Piotroski ScoreFundamental quality 0–957
Debt / EquityFinancial leverage0.34x0.52x
Net DebtTotal debt minus cash$2.7B$667M
Cash & Equiv.Liquid assets$111M$2.0B
Total DebtShort + long-term debt$2.8B$2.6B
Interest CoverageEBIT ÷ Interest expense6.40x8.00x
HOLX leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HOLX leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in HOLX five years ago would be worth $11,582 today (with dividends reinvested), compared to $6,049 for COO. Over the past 12 months, HOLX leads with a +37.1% total return vs COO's -24.8%. The 3-year compound annual growth rate (CAGR) favors HOLX at -2.9% vs COO's -14.1% — a key indicator of consistent wealth creation.

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
YTD ReturnYear-to-date-24.7%+1.9%
1-Year ReturnPast 12 months-24.8%+37.1%
3-Year ReturnCumulative with dividends-36.7%-8.5%
5-Year ReturnCumulative with dividends-39.5%+15.8%
10-Year ReturnCumulative with dividends+57.9%+124.3%
CAGR (3Y)Annualised 3-year return-14.1%-2.9%
HOLX leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

HOLX leads this category, winning 2 of 2 comparable metrics.

HOLX is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than COO's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs COO's 68.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
Beta (5Y)Sensitivity to S&P 5000.93x0.41x
52-Week HighHighest price in past year$89.83$76.04
52-Week LowLowest price in past year$60.00$52.81
% of 52W HighCurrent price vs 52-week peak+68.0%+100.0%
RSI (14)Momentum oscillator 0–10024.769.1
Avg Volume (50D)Average daily shares traded2.0M10.0M
HOLX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates COO as "Buy" and HOLX as "Hold". Consensus price targets imply 53.6% upside for COO (target: $94) vs 3.9% for HOLX (target: $79).

MetricCOO logoCOOThe Cooper Compan…HOLX logoHOLXHologic, Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$93.86$79.00
# AnalystsCovering analysts2442
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.4%+4.4%
Insufficient data to determine a leader in this category.
Key Takeaway

HOLX leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). COO leads in 1 (Valuation Metrics). 1 tied.

Best OverallHologic, Inc. (HOLX)Leads 3 of 6 categories
Loading custom metrics...

COO vs HOLX: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is COO or HOLX a better buy right now?

For growth investors, The Cooper Companies, Inc.

(COO) is the stronger pick with 5. 1% revenue growth year-over-year, versus 1. 7% for Hologic, Inc. (HOLX). Hologic, Inc. (HOLX) offers the better valuation at 30. 5x trailing P/E (17. 2x forward), making it the more compelling value choice. Analysts rate The Cooper Companies, Inc. (COO) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — COO or HOLX?

On trailing P/E, Hologic, Inc.

(HOLX) is the cheapest at 30. 5x versus The Cooper Companies, Inc. at 32. 7x. On forward P/E, The Cooper Companies, Inc. is actually cheaper at 13. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — COO or HOLX?

Over the past 5 years, Hologic, Inc.

(HOLX) delivered a total return of +15. 8%, compared to -39. 5% for The Cooper Companies, Inc. (COO). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus COO's +57. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — COO or HOLX?

By beta (market sensitivity over 5 years), Hologic, Inc.

(HOLX) is the lower-risk stock at 0. 41β versus The Cooper Companies, Inc. 's 0. 93β — meaning COO is approximately 127% more volatile than HOLX relative to the S&P 500. On balance sheet safety, The Cooper Companies, Inc. (COO) carries a lower debt/equity ratio of 34% versus 52% for Hologic, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — COO or HOLX?

By revenue growth (latest reported year), The Cooper Companies, Inc.

(COO) is pulling ahead at 5. 1% versus 1. 7% for Hologic, Inc. (HOLX). On earnings-per-share growth, the picture is similar: The Cooper Companies, Inc. grew EPS -4. 6% year-over-year, compared to -25. 0% for Hologic, Inc.. Over a 3-year CAGR, COO leads at 7. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — COO or HOLX?

Hologic, Inc.

(HOLX) is the more profitable company, earning 13. 8% net margin versus 9. 2% for The Cooper Companies, Inc. — meaning it keeps 13. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOLX leads at 17. 4% versus 16. 7% for COO. At the gross margin level — before operating expenses — HOLX leads at 61. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is COO or HOLX more undervalued right now?

On forward earnings alone, The Cooper Companies, Inc.

(COO) trades at 13. 2x forward P/E versus 17. 2x for Hologic, Inc. — 4. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COO: 53. 6% to $93. 86.

08

Which pays a better dividend — COO or HOLX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is COO or HOLX better for a retirement portfolio?

For long-horizon retirement investors, Hologic, Inc.

(HOLX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +124. 3% 10Y return). Both have compounded well over 10 years (HOLX: +124. 3%, COO: +57. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between COO and HOLX?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

COO

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

HOLX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform COO and HOLX on the metrics below

Revenue Growth>
%
(COO: 6.2% · HOLX: 2.5%)
Net Margin>
%
(COO: 9.7% · HOLX: 13.2%)
P/E Ratio<
x
(COO: 32.7x · HOLX: 30.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.